Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Body weight loss is a simple and useful indicator of prognosis and predictive tolerability in the first year of nintedanib therapy in patients with interstitial lung disease.
Respir Investig. 2024 Apr 24;62(4):551-557. doi: 10.1016/j.resinv.2024.04.011. Online ahead of print.
Respir Investig. 2024.
PMID: 38663299
Cite
Cite